A citation-based method for searching scientific literature

Aleksandra Janusz, Jacek Milek, Malgorzata Perycz, Laura Pacini, Claudia Bagni, Leszek Kaczmarek, Magdalena Dziembowska. J Neurosci 2013
Times Cited: 80







List of co-cited articles
1422 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Minocycline promotes dendritic spine maturation and improves behavioural performance in the fragile X mouse model.
T V Bilousova, L Dansie, M Ngo, J Aye, J R Charles, D W Ethell, I M Ethell. J Med Genet 2009
318
62

Genetic removal of matrix metalloproteinase 9 rescues the symptoms of fragile X syndrome in a mouse model.
Harpreet Sidhu, Lorraine E Dansie, Peter W Hickmott, Douglas W Ethell, Iryna M Ethell. J Neurosci 2014
109
52

FMRP stalls ribosomal translocation on mRNAs linked to synaptic function and autism.
Jennifer C Darnell, Sarah J Van Driesche, Chaolin Zhang, Ka Ying Sharon Hung, Aldo Mele, Claire E Fraser, Elizabeth F Stone, Cynthia Chen, John J Fak, Sung Wook Chi,[...]. Cell 2011
41

High MMP-9 activity levels in fragile X syndrome are lowered by minocycline.
Magdalena Dziembowska, Dalyir I Pretto, Aleksandra Janusz, Leszek Kaczmarek, Mary Jacena Leigh, Nielsen Gabriel, Blythe Durbin-Johnson, Randi J Hagerman, Flora Tassone. Am J Med Genet A 2013
109
36

Activity-dependent local translation of matrix metalloproteinase-9.
Magdalena Dziembowska, Jacek Milek, Aleksandra Janusz, Emilia Rejmak, Ewelina Romanowska, Tomasz Gorkiewicz, Adrian Tiron, Clive R Bramham, Leszek Kaczmarek. J Neurosci 2012
88
36

Pharmacogenetic inhibition of eIF4E-dependent Mmp9 mRNA translation reverses fragile X syndrome-like phenotypes.
Christos G Gkogkas, Arkady Khoutorsky, Ruifeng Cao, Seyed Mehdi Jafarnejad, Masha Prager-Khoutorsky, Nikolaos Giannakas, Archontia Kaminari, Apostolia Fragkouli, Karim Nader, Theodore J Price,[...]. Cell Rep 2014
124
36

A randomized double-blind, placebo-controlled trial of minocycline in children and adolescents with fragile x syndrome.
Mary Jacena S Leigh, Danh V Nguyen, Yi Mu, Tri I Winarni, Andrea Schneider, Tasleem Chechi, Jonathan Polussa, Paul Doucet, Flora Tassone, Susan M Rivera,[...]. J Dev Behav Pediatr 2013
155
33

The mGluR theory of fragile X mental retardation.
Mark F Bear, Kimberly M Huber, Stephen T Warren. Trends Neurosci 2004
32

Matrix metalloproteinase-9 is required for hippocampal late-phase long-term potentiation and memory.
Vanja Nagy, Ozlem Bozdagi, Anna Matynia, Marcin Balcerzyk, Pawel Okulski, Joanna Dzwonek, Rui M Costa, Alcino J Silva, Leszek Kaczmarek, George W Huntley. J Neurosci 2006
353
32

Influence of matrix metalloproteinase MMP-9 on dendritic spine morphology.
Piotr Michaluk, Marcin Wawrzyniak, Przemyslaw Alot, Marcin Szczot, Paulina Wyrembek, Katarzyna Mercik, Nikolay Medvedev, Ewa Wilczek, Mathias De Roo, Werner Zuschratter,[...]. J Cell Sci 2011
157
31

Extracellular proteolysis by matrix metalloproteinase-9 drives dendritic spine enlargement and long-term potentiation coordinately.
Xiao-bin Wang, Ozlem Bozdagi, Jessica S Nikitczuk, Zu Wei Zhai, Qiang Zhou, George W Huntley. Proc Natl Acad Sci U S A 2008
245
30

Open-label add-on treatment trial of minocycline in fragile X syndrome.
Carlo Paribello, Leeping Tao, Anthony Folino, Elizabeth Berry-Kravis, Michael Tranfaglia, Iryna M Ethell, Douglas W Ethell. BMC Neurol 2010
155
27


Altered synaptic plasticity in a mouse model of fragile X mental retardation.
Kimberly M Huber, Sean M Gallagher, Stephen T Warren, Mark F Bear. Proc Natl Acad Sci U S A 2002
967
23

Important role of matrix metalloproteinase 9 in epileptogenesis.
Grzegorz M Wilczynski, Filip A Konopacki, Ewa Wilczek, Zofia Lasiecka, Adam Gorlewicz, Piotr Michaluk, Marcin Wawrzyniak, Monika Malinowska, Pawel Okulski, Lukasz R Kolodziej,[...]. J Cell Biol 2008
210
23

Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome.
A J Verkerk, M Pieretti, J S Sutcliffe, Y H Fu, D P Kuhl, A Pizzuti, O Reiner, S Richards, M F Victoria, F P Zhang. Cell 1991
22

Abnormal dendritic spines in fragile X knockout mice: maturation and pruning deficits.
T A Comery, J B Harris, P J Willems, B A Oostra, S A Irwin, I J Weiler, W T Greenough. Proc Natl Acad Sci U S A 1997
775
18

Long-lasting effects of minocycline on behavior in young but not adult Fragile X mice.
L E Dansie, K Phommahaxay, A G Okusanya, J Uwadia, M Huang, S E Rotschafer, K A Razak, D W Ethell, I M Ethell. Neuroscience 2013
63
23

Genetic removal of p70 S6 kinase 1 corrects molecular, synaptic, and behavioral phenotypes in fragile X syndrome mice.
Aditi Bhattacharya, Hanoch Kaphzan, Amanda C Alvarez-Dieppa, Jaclyn P Murphy, Philippe Pierre, Eric Klann. Neuron 2012
211
18

Dysregulation of mTOR signaling in fragile X syndrome.
Ali Sharma, Charles A Hoeffer, Yukihiro Takayasu, Takahiro Miyawaki, Sean M McBride, Eric Klann, R Suzanne Zukin. J Neurosci 2010
400
18

Minocycline treatment reverses ultrasonic vocalization production deficit in a mouse model of Fragile X Syndrome.
Sarah E Rotschafer, Michael S Trujillo, Lorraine E Dansie, Iryna M Ethell, Khaleel A Razak. Brain Res 2012
83
18

Matrix metalloproteinase-9 undergoes expression and activation during dendritic remodeling in adult hippocampus.
Arek Szklarczyk, Joanna Lapinska, Marcin Rylski, Ronald D G McKay, Leszek Kaczmarek. J Neurosci 2002
302
18

Correction of fragile X syndrome in mice.
Gül Dölen, Emily Osterweil, B S Shankaranarayana Rao, Gordon B Smith, Benjamin D Auerbach, Sumantra Chattarji, Mark F Bear. Neuron 2007
693
17


Dynamic translational and proteasomal regulation of fragile X mental retardation protein controls mGluR-dependent long-term depression.
Lingfei Hou, Marcia D Antion, Daoying Hu, Corinne M Spencer, Richard Paylor, Eric Klann. Neuron 2006
349
17

Matrix metalloproteinases regulate the formation of dendritic spine head protrusions during chemically induced long-term potentiation.
Zsuzsanna Szepesi, Monika Bijata, Blazej Ruszczycki, Leszek Kaczmarek, Jakub Wlodarczyk. PLoS One 2013
48
29

Electrocortical changes associated with minocycline treatment in fragile X syndrome.
Andrea Schneider, Mary Jacena Leigh, Patrick Adams, Rawi Nanakul, Tasleem Chechi, John Olichney, Randi Hagerman, David Hessl. J Psychopharmacol 2013
72
19

Synaptically released matrix metalloproteinase activity in control of structural plasticity and the cell surface distribution of GluA1-AMPA receptors.
Zsuzsanna Szepesi, Eric Hosy, Blazej Ruszczycki, Monika Bijata, Marta Pyskaty, Arthur Bikbaev, Martin Heine, Daniel Choquet, Leszek Kaczmarek, Jakub Wlodarczyk. PLoS One 2014
56
25

Activation of NMDA receptors promotes dendritic spine development through MMP-mediated ICAM-5 cleavage.
Li Tian, Michael Stefanidakis, Lin Ning, Philippe Van Lint, Henrietta Nyman-Huttunen, Claude Libert, Shigeyoshi Itohara, Masayoshi Mishina, Heikki Rauvala, Carl G Gahmberg. J Cell Biol 2007
138
17

Transsynaptic signaling by activity-dependent cleavage of neuroligin-1.
Rui T Peixoto, Portia A Kunz, Hyungbae Kwon, Angela M Mabb, Bernardo L Sabatini, Benjamin D Philpot, Michael D Ehlers. Neuron 2012
155
17

Genetic Reduction of Matrix Metalloproteinase-9 Promotes Formation of Perineuronal Nets Around Parvalbumin-Expressing Interneurons and Normalizes Auditory Cortex Responses in Developing Fmr1 Knock-Out Mice.
Teresa H Wen, Sonia Afroz, Sarah M Reinhard, Arnold R Palacios, Kendal Tapia, Devin K Binder, Khaleel A Razak, Iryna M Ethell. Cereb Cortex 2018
68
20


Experience-dependent plasticity of the barrel cortex in mice observed with 2-DG brain mapping and c-Fos: effects of MMP-9 KO.
Aleksandra Kaliszewska, Monika Bijata, Leszek Kaczmarek, Malgorzata Kossut. Cereb Cortex 2012
40
32

Matrix metalloproteinase-dependent shedding of intercellular adhesion molecule-5 occurs with long-term potentiation.
K Conant, Y Wang, A Szklarczyk, A Dudak, M P Mattson, S T Lim. Neuroscience 2010
86
16

TIMP-1 abolishes MMP-9-dependent long-lasting long-term potentiation in the prefrontal cortex.
Pawel Okulski, Therese M Jay, Jacek Jaworski, Kamila Duniec, Joanna Dzwonek, Filip A Konopacki, Grzegorz M Wilczynski, Amelia Sánchez-Capelo, Jacques Mallet, Leszek Kaczmarek. Biol Psychiatry 2007
119
16

Reward learning requires activity of matrix metalloproteinase-9 in the central amygdala.
Ewelina Knapska, Victoria Lioudyno, Anna Kiryk, Marta Mikosz, Tomasz Górkiewicz, Piotr Michaluk, Maciej Gawlak, Mayank Chaturvedi, Gabriela Mochol, Marcin Balcerzyk,[...]. J Neurosci 2013
45
28

Beta-dystroglycan as a target for MMP-9, in response to enhanced neuronal activity.
Piotr Michaluk, Lukasz Kolodziej, Barbara Mioduszewska, Grzegorz M Wilczynski, Joanna Dzwonek, Jacek Jaworski, Dariusz C Gorecki, Ole Petter Ottersen, Leszek Kaczmarek. J Biol Chem 2007
153
16

Matrix metalloproteinase-9 deletion rescues auditory evoked potential habituation deficit in a mouse model of Fragile X Syndrome.
Jonathan W Lovelace, Teresa H Wen, Sarah Reinhard, Mike S Hsu, Harpreet Sidhu, Iryna M Ethell, Devin K Binder, Khaleel A Razak. Neurobiol Dis 2016
60
21

Suppression of two major Fragile X Syndrome mouse model phenotypes by the mGluR5 antagonist MPEP.
Q J Yan, M Rammal, M Tranfaglia, R P Bauchwitz. Neuropharmacology 2005
393
15


Chronic pharmacological mGlu5 inhibition corrects fragile X in adult mice.
Aubin Michalon, Michael Sidorov, Theresa M Ballard, Laurence Ozmen, Will Spooren, Joseph G Wettstein, Georg Jaeschke, Mark F Bear, Lothar Lindemann. Neuron 2012
350
15

Altered mTOR signaling and enhanced CYFIP2 expression levels in subjects with fragile X syndrome.
C A Hoeffer, E Sanchez, R J Hagerman, Y Mu, D V Nguyen, H Wong, A M Whelan, R S Zukin, E Klann, F Tassone. Genes Brain Behav 2012
129
15

MMP9: a novel function in synaptic plasticity.
Magdalena Dziembowska, Jakub Wlodarczyk. Int J Biochem Cell Biol 2012
83
15

In vivo roles for matrix metalloproteinase-9 in mature hippocampal synaptic physiology and plasticity.
Ozlem Bozdagi, Vanja Nagy, Kimberly T Kwei, George W Huntley. J Neurophysiol 2007
132
15

Effects of extracellular matrix-degrading proteases matrix metalloproteinases 3 and 9 on spatial learning and synaptic plasticity.
Starla E Meighan, Peter C Meighan, Papiya Choudhury, Christopher J Davis, Mikel L Olson, Peter A Zornes, John W Wright, Joseph W Harding. J Neurochem 2006
210
15

Lovastatin corrects excess protein synthesis and prevents epileptogenesis in a mouse model of fragile X syndrome.
Emily K Osterweil, Shih-Chieh Chuang, Alexander A Chubykin, Michael Sidorov, Riccardo Bianchi, Robert K S Wong, Mark F Bear. Neuron 2013
156
15

Effects of STX209 (arbaclofen) on neurobehavioral function in children and adults with fragile X syndrome: a randomized, controlled, phase 2 trial.
Elizabeth M Berry-Kravis, David Hessl, Barbara Rathmell, Peter Zarevics, Maryann Cherubini, Karen Walton-Bowen, Yi Mu, Danh V Nguyen, Joseph Gonzalez-Heydrich, Paul P Wang,[...]. Sci Transl Med 2012
226
15


Maintenance of long-term potentiation in hippocampal mossy fiber-CA3 pathway requires fine-tuned MMP-9 proteolytic activity.
Grzegorz Wiera, Grazyna Wozniak, Malgorzata Bajor, Leszek Kaczmarek, Jerzy W Mozrzymas. Hippocampus 2013
41
29

FMRP targets distinct mRNA sequence elements to regulate protein expression.
Manuel Ascano, Neelanjan Mukherjee, Pradeep Bandaru, Jason B Miller, Jeffrey D Nusbaum, David L Corcoran, Christine Langlois, Mathias Munschauer, Scott Dewell, Markus Hafner,[...]. Nature 2012
446
15


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.